Decoy Therapeutics, Inc. (DCOY)
0.63
-0.05
(-7.62%)
USD |
NASDAQ |
Feb 04, 16:00
0.633
0.00 (0.00%)
After-Hours: 20:00
Decoy Therapeutics Shareholders Equity (Quarterly) : 4.248M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Amgen, Inc. | 8.658B |
| CorMedix, Inc. | 374.13M |
| Vor Biopharma, Inc. | -2.225B |
| Humacyte, Inc. | -4.751M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.097M |
| Total Liabilities (Quarterly) | 1.849M |
| Current Ratio | 2.791 |